Ad Law Access

Updates on advertising law and privacy law trends, issues, and developments

Misguided: The FTC Attempts to Redefine the Law with its Health Products Compliance Guidance

Yesterday, the FTC’s Bureau of Consumer Protection released its Health Products Compliance Guidance —a sweeping overhaul of the 1998 Guidance, Dietary Supplements: An Advertising Guide for Industry . Unlike the…

FDA Expands Scope of Reporting for Discontinued Drugs

The FDA has published an interim final rule amending definitions related to required notifications regarding drug shortages. 21 C.F.R. 314.81(b)(3)(iii) requires an applicant who is the sole manufacturer certain…

FDA makes "Quantitative Summary of the Benefits and Risks of Prescription Drugs: A Literature Review" available for comment

On December 13, 2011, FDA announced the availability of a draft report entitled “Quantitative Summary of the Benefits and Risks of Prescription Drugs: A Literature Review” for public comment. The literature review was…

FDA Proposes "Experimental Study of Comparative Direct-to-Consumer Advertising"

On December 9, 2011, the Food & Drug Administration (FDA) issued a notice announcing that a proposal to collect information for a “Experimental Study of Comparative Direct-to-Consumer Advertising” had been submitted to…

FDA Notice Clarifies Past Federal Preemption Policy Statements

The Food and Drug Administration (“FDA”) recently completed an evaluation of the legal basis for federal preemption policy statements the agency has issued under the Federal Food, Drug & Cosmetic Act (“FDCA”) during…